146 related articles for article (PubMed ID: 35000271)
1. Desmoglein-3 induces YAP phosphorylation and inactivation during collective migration of oral carcinoma cells.
Ahmad US; Parkinson EK; Wan H
Mol Oncol; 2022 Apr; 16(8):1625-1649. PubMed ID: 35000271
[TBL] [Abstract][Full Text] [Related]
2. Genome-wide CRISPR screens of oral squamous cell carcinoma reveal fitness genes in the Hippo pathway.
Chai AWY; Yee PS; Price S; Yee SM; Lee HM; Tiong VK; Gonçalves E; Behan FM; Bateson J; Gilbert J; Tan AC; McDermott U; Garnett MJ; Cheong SC
Elife; 2020 Sep; 9():. PubMed ID: 32990596
[TBL] [Abstract][Full Text] [Related]
3. Genomic Hippo Pathway Alterations and Persistent YAP/TAZ Activation: New Hallmarks in Head and Neck Cancer.
Faraji F; Ramirez SI; Anguiano Quiroz PY; Mendez-Molina AN; Gutkind JS
Cells; 2022 Apr; 11(8):. PubMed ID: 35456049
[TBL] [Abstract][Full Text] [Related]
4. Reversal of cisplatin resistance in oral squamous cell carcinoma by piperlongumine loaded smart nanoparticles through inhibition of Hippo-YAP signaling pathway.
Sa P; Singh P; Panda S; Swain RK; Dash R; Sahoo SK
Transl Res; 2024 Jun; 268():63-78. PubMed ID: 38499286
[TBL] [Abstract][Full Text] [Related]
5. Hippo-YAP signaling activation and cross-talk with PI3K in oral cancer: A retrospective cohort study.
Rodrigo JP; Rodríguez-Santamarta T; Corte D; García-de-la-Fuente V; Rodríguez-Torres N; Lequerica-Fernández P; Lorz C; García-Pedrero JM; de Vicente JC
Oral Dis; 2024 Mar; 30(2):149-162. PubMed ID: 35951471
[TBL] [Abstract][Full Text] [Related]
6. The Hippo-YAP signaling pathway drives CD24-mediated immune evasion in esophageal squamous cell carcinoma via macrophage phagocytosis.
Zhou X; Yan Z; Hou J; Zhang L; Chen Z; Gao C; Ahmad NH; Guo M; Wang W; Han T; Chang T; Kang X; Wang L; Liang Y; Li X
Oncogene; 2024 Feb; 43(7):495-510. PubMed ID: 38168654
[TBL] [Abstract][Full Text] [Related]
7. From the Matrix to the Nucleus and Back: Mechanobiology in the Light of Health, Pathologies, and Regeneration of Oral Periodontal Tissues.
Dieterle MP; Husari A; Steinberg T; Wang X; Ramminger I; Tomakidi P
Biomolecules; 2021 May; 11(6):. PubMed ID: 34073044
[TBL] [Abstract][Full Text] [Related]
8. The significance of Hippo pathway protein expression in oral squamous cell carcinoma.
Amano Y; Matsubara D; Kihara A; Yoshimoto T; Fukushima N; Nishino H; Mori Y; Niki T
Front Med (Lausanne); 2024; 11():1247625. PubMed ID: 38444414
[TBL] [Abstract][Full Text] [Related]
9. YAP induces FAK phosphorylation to inhibit gastric cancer cell proliferation via upregulation of HMGB1.
Jiang Y; Fu L; Liu B; Li F
Int J Biol Macromol; 2024 Mar; 262(Pt 1):130037. PubMed ID: 38331059
[TBL] [Abstract][Full Text] [Related]
10. FTO attenuates the cytotoxicity of cisplatin in KGN granulosa cell-like tumour cells by regulating the Hippo/YAP1 signalling pathway.
Wang R; Cheng F; Yang X
J Ovarian Res; 2024 Mar; 17(1):62. PubMed ID: 38491479
[TBL] [Abstract][Full Text] [Related]
11. YAP1 is a potent driver of the onset and progression of oral squamous cell carcinoma.
Omori H; Nishio M; Masuda M; Miyachi Y; Ueda F; Nakano T; Sato K; Mimori K; Taguchi K; Hikasa H; Nishina H; Tashiro H; Kiyono T; Mak TW; Nakao K; Nakagawa T; Maehama T; Suzuki A
Sci Adv; 2020 Mar; 6(12):eaay3324. PubMed ID: 32206709
[TBL] [Abstract][Full Text] [Related]
12. VAV2 orchestrates the interplay between regenerative proliferation and ribogenesis in both keratinocytes and oral squamous cell carcinoma.
Fernández-Parejo N; Lorenzo-Martín LF; García-Pedrero JM; Rodrigo JP; Dosil M; Bustelo XR
Sci Rep; 2024 Feb; 14(1):4060. PubMed ID: 38374399
[TBL] [Abstract][Full Text] [Related]
13. Manganese drives ferroptosis of cancer cells via YAP/TAZ phase separation activated ACSL4 in OSCC.
Chen H; Cui H; Liu W; Li BW; Tian Z; Zhao YY; Yu GT
Oral Dis; 2024 Mar; ():. PubMed ID: 38462885
[TBL] [Abstract][Full Text] [Related]
14. Comparative Transcriptome Analysis Identifies Desmoglein-3 as a Potential Oncogene in Oral Cancer Cells.
Wan H; Teh MT; Mastroianni G; Ahmad US
Cells; 2023 Nov; 12(23):. PubMed ID: 38067138
[TBL] [Abstract][Full Text] [Related]
15. A non-canonical Hippo pathway represses the expression of ΔNp63.
Low-Calle AM; Ghoneima H; Ortega N; Cuibus AM; Katz C; Tong D; Prives C; Prywes R
bioRxiv; 2023 Feb; ():. PubMed ID: 36824867
[TBL] [Abstract][Full Text] [Related]
16. Tubuloside B, a major constituent of Cistanche deserticola, inhibits migration of hepatocellular carcinoma by inhibiting Hippo-YAP pathway.
Yao J; Wan H; Zhang J; Shen W; Wei X; Shi C; Ou B; Liu D; Ge L; Fei J; Zeng X
Phytomedicine; 2024 Mar; 129():155552. PubMed ID: 38552378
[TBL] [Abstract][Full Text] [Related]
17. Exchangeable leaders of collectively migrating glioma abuse N-cadherin trafficking.
Kawauchi T; Ito S
J Cell Biol; 2024 Jun; 223(6):. PubMed ID: 38700903
[TBL] [Abstract][Full Text] [Related]
18. Hippo signaling mediates proliferation, invasiveness, and metastatic potential of clear cell renal cell carcinoma.
Schütte U; Bisht S; Heukamp LC; Kebschull M; Florin A; Haarmann J; Hoffmann P; Bendas G; Buettner R; Brossart P; Feldmann G
Transl Oncol; 2014 Apr; 7(2):309-21. PubMed ID: 24913676
[TBL] [Abstract][Full Text] [Related]
19. NFAT5 promotes oral squamous cell carcinoma progression in a hyperosmotic environment.
Yoshimoto S; Morita H; Matsuda M; Katakura Y; Hirata M; Hashimoto S
Lab Invest; 2021 Jan; 101(1):38-50. PubMed ID: 32901097
[TBL] [Abstract][Full Text] [Related]
20. USP12 facilitates gastric cancer progression via stabilizing YAP.
Zhang P; Liu D; Zang Y; Wang J; Liu Z; Zhu J; Li X; Ding Y
Cell Death Discov; 2024 Apr; 10(1):174. PubMed ID: 38605077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
